Page last updated: 2024-11-13

2-ethylammonio-1-(3,4-methylenedioxyphenyl)propane-1-one chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-ethylammonio-1-(3,4-methylenedioxyphenyl)propane-1-one chloride: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID57252245
SCHEMBL ID2641160
MeSH IDM000607795

Synonyms (18)

Synonym
bk-mdea
2-ethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one
2-ethylammonio-1-(3,4-methylenedioxyphenyl)propane-1-one chloride
l91c78fw96 ,
unii-l91c78fw96
3,4-methylenedioxy-n-ethylcathinone
1112937-64-0
ethylone
SCHEMBL2641160
MJEMIOXXNCZZFK-UHFFFAOYSA-N
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one
1-propanone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-
1-(benzo(d)(1,3)dioxol-5-yl)-2-(ethylamino)propan-1-one
bk-mde
mdec
J2.528.311B ,
DTXSID20894842
Q5404507

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Following the training, dose substitution was used to generate full dose-response curves for METH and the three synthetic cathinones."( Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.
Du, H; Fu, D; Lai, M; Liu, H; Wang, Y; Xu, P; Xu, Z; Zhou, W, 2022
)
0.72
"Dibutylone, ethylone, and N-ethylpentylone functioned as reinforcers, and the inverted U-shaped dose-response curves were obtained."( Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.
Du, H; Fu, D; Lai, M; Liu, H; Wang, Y; Xu, P; Xu, Z; Zhou, W, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.05 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (11.11%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]